Variant #0000455841 (NC_000016.9:g.2120532T>C, NM_000548.3:c.1792T>C (TSC2))
| Chromosome |
16 |
| Allele |
Unknown |
| Affects function (as reported) |
Affects function |
| Affects function (by curator) |
Not classified |
| Classification method |
- |
| Clinical classification |
NA |
| DNA change (genomic) (Relative to hg19 / GRCh37) |
g.2120532T>C |
| DNA change (hg38) |
g.2070531T>C |
| Published as |
- |
| ISCN |
- |
| DB-ID |
TSC2_000420 See all 8 reported entries |
| Variant remarks |
phosphorylation of S6K T389 significantly higher than wild type TSC2 thus TSC1-TSC2 complex-dependent inhibition of mTOR activity affected; significant reduction in TSC1 signal seen and TSC1-TSC2 binding reduced hence variant is destabilising; tested in both human and mouse in vitro systems |
| Reference |
PubMed: Hoogeveen-Westerveld, 2011 |
| ClinVar ID |
- |
| dbSNP ID |
- |
| Origin |
In vitro (cloned) |
| Segregation |
- |
| Frequency |
- |
| Re-site |
- |
| VIP |
- |
| Methylation |
- |
| Average frequency (gnomAD v.2.1.1) |
Retrieve |
| Owner |
Rosemary Ekong |
| Database submission license |
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International |
| Created by |
Rosemary Ekong |
| Date created |
2013-06-12 02:25:54 +02:00 (CEST) |
| Date last edited |
2021-04-23 13:58:39 +02:00 (CEST) |

Variant on transcripts
|